Home・Akcijų sąrašas・Medtronic PLC

Medtronic PLC

Uždarymo kaina

SektoriusSveikatos priežiūra

91.22 0.78

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

90.18

Max

91.97

Pagrindiniai rodikliai
By Trading Economics
Pajamos	130M 1.3B
Pardavimai	789M 9.8B
P/E Sektoriaus vid.	23.345 57.002
Pelnas, tenkantis vienai akcijai	1.55
Dividendų pajamingumas	3.26
Pelno marža	12.981
Darbuotojai	95,000
EBITDA	147M 2.6B

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+5.46% upside

Dividendai
By Acuity
Dividendų pajamingumas Sektoriaus vid.	3.26% 2.22%
Kitas uždarbis	2026-09-01
Kitas dividendų mokėjimo data	2026-10-16
Kita Ex Dividend data	2026-09-25

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	14B 109B
Ankstesnė atidarymo kaina	90.44
Ankstesnė uždarymo kaina	91.22

Naujienos nuotaikos

By Acuity

20%

80%

58 / 340 reitingas Healthcare

Medtronic PLC Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-14 21:51; UTC

Medtronic PLC shares are lower in after-market hours, with no specific news cited. Broader market declines follow a report of falling U.S. retail sales.

2026-08-13 23:01; UTC

Medtronic PLC shares are lower in after-market hours, continuing a decline from earlier losses amid mixed signals on labor market strength and inflation.

2026-08-12 23:01; UTC

Medtronic PLC shares are lower in after-market trading, reflecting a retracement from an earlier peak while remaining above the 20-day moving average.

2026-08-11 23:01; UTC

Shares of Medtronic PLC were lower during after-market hours, despite a brief uptick earlier in the session. No specific news was identified.

2026-08-10 23:21; UTC

Medtronic PLC shares are higher in after-market trading, continuing an upward trend since Monday's close and remaining above the 20-day moving average.

2026-08-08 00:02; UTC

Medtronic PLC shares are lower in after-market hours amid a volatile session. A weak jobs report has influenced broader market expectations for interest rate hikes.

2026-08-07 23:26; UTC

Medtronic PLC shares are higher in after-market hours, supported by overall market strength and strong performances from major tech stocks.

2026-08-06 20:06; UTC

News

Medtronic PLC announced expanded CE Mark approval for its Sphere-9 Catheter, yet shares are trading lower since Wednesday's close after an earlier uptick.

2026-08-05 19:52; UTC

News

Medtronic PLC shares are lower today amid increased put options volume, reflecting bearish sentiment ahead of the upcoming earnings report on September 1st.

2026-08-04 20:06; UTC

News

Medtronic PLC shares are lower after a jury ruled the company owes $88 million for damages related to Covidien's hernia mesh products.

2026-08-03 23:02; UTC

Medtronic PLC shares are lower in after-market hours, reflecting selling pressure despite trading above its 20-day moving average. No specific news was identified.

2026-07-31 23:46; UTC

Medtronic PLC shares are trading higher in after-market hours, following unusual trading activity and amid rising U.S. Treasury yields and crude oil prices.

2026-07-30 23:31; UTC

Medtronic PLC shares are modestly higher in after-market trading, remaining near the upper end of their one-month range. No specific news was identified.

2026-07-29 21:51; UTC

Medtronic PLC shares are lower in after-market hours, reflecting broader market declines amid renewed inflation and interest rate concerns linked to rising crude oil prices.

2026-07-28 23:26; UTC

Shares of Medtronic PLC are trading higher in after-market hours, maintaining above the 20-day moving average amid a trend of five consecutive daily gains.

2026-07-27 23:46; UTC

Medtronic PLC shares are trading higher in after-market hours, continuing an upward trend and supported by positive sentiment in European markets.

2026-07-24 23:26; UTC

Medtronic PLC's after-market trading remains roughly flat, showing routine performance within a narrow range since Friday's close.

2026-07-23 23:02; UTC

Medtronic PLC shares are trading higher in after-market hours, reaching near the top of their one-month trading range amid broader market stability.

2026-07-22 19:36; UTC

News

Medtronic PLC shares are lower as competition increases from Johnson & Johnson's newly authorized Ottava Surgical Robot for U.S. robotic soft-tissue surgery.

2026-07-21 20:07; UTC

News

Medtronic PLC shares are lower today, impacted by declines in the Health Care Equipment sector. The company recently launched its AI-native surgical platform, Touch Surgery™ Aide.

2026-07-20 22:31; UTC

Medtronic PLC shares are higher in after-market hours, reflecting positive movement in the Health Care Equipment sub-sector. The stock remains above its 20-day moving average.

Akcijų palyginimas

Kainos pokytis

Medtronic PLC Prognozė

Kainos tikslas

By TipRanks

5.46% į viršų

12 mėnesių prognozė

Vidutinis 95.53 USD 5.46%

Aukščiausias 118 USD

Žemiausias 80 USD

Remiantis 19 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Medtronic PLC kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

19 ratings

Pirkti

Laikyti

Parduoti

Remiantis 19 analitikų, pateikusių Medtronic PLC akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Rinkos nuotaikos

By Acuity

58 / 340 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.